Celltrion Pharm, Inc. (KOSDAQ:068760)
47,300
+300 (0.64%)
May 14, 2025, 3:30 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.04 trillion as of May 13, 2025. Its market cap has decreased by -48.11% in one year.
Market Cap
2.04T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
78.99
Stock Price
47,300.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.04T, an increase of 2,979.62%. That is a compound annual growth rate of 19.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 13, 2025 | 2,043.99B | -17.13% |
Dec 30, 2024 | 2,466.43B | -35.41% |
Dec 28, 2023 | 3,818.49B | 44.48% |
Dec 29, 2022 | 2,642.93B | -43.45% |
Dec 30, 2021 | 4,673.68B | -46.31% |
Dec 30, 2020 | 8,705.45B | 511.51% |
Dec 30, 2019 | Pro | Pro |
Dec 28, 2018 | Pro | Pro |
Dec 28, 2017 | Pro | Pro |
Dec 29, 2016 | Pro | Pro |
Dec 30, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 74.02T |
Celltrion | 33.69T |
ALTEOGEN | 18.39T |
Yuhan | 8,026.78B |
HLB Co., Ltd. | 7,581.42B |
SK Biopharmaceuticals | 7,079.52B |
PharmaResearch | 4,171.44B |
Peptron | 3,872.02B |